drugset
drugset / Trial / NCT00985478

First in Man Study With SLV342

NCT00985478 ↗

Phase 1 Terminated 48 enrolled Abbott Products Quintiles, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

First in man study with single and multiple rising doses with SLV342

Timeline

Start
2010-01
Primary completion
2010-06
Completion
2010-06

Outcome

Outcome not reported

Stopped (Business): “Terminated on 14 Sep 2010 due to strategic considerations”

Drugs

EvaluationDrugModalityDoseRoute
Subject SLV342 Unknown 25 mg —

Indications

No indication recorded.